Fondaparinux prevents venous thromboembolism after joint replacement surgery in Japanese patients

International Orthopaedics

Volumn 32, Issue 4, 2008, Pages 443-451

  Fuji, Takeshi ^a   Fujita, Satoru ^b   Ochi, Takahiro ^c  

^a OSAKA KOSEI NENKIN HOSPITAL   (Japan)

^b Takarazuka Daiichi Hospital   (Japan)

^c SAGAMIHARA NATIONAL HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

FONDAPARINUX; PLACEBO;

ADULT; AGED; ARTICLE; BLEEDING; BRAIN INFARCTION; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INCIDENCE; JAPANESE; JOINT PROSTHESIS; LIVER DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN NECROSIS; SUPRAVENTRICULAR TACHYCARDIA; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; VENOUS THROMBOEMBOLISM;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; JAPAN; MALE; PLACEBOS; POLYSACCHARIDES; TREATMENT OUTCOME; VENOUS THROMBOEMBOLISM;

EID: 46149101230     PISSN: 03412695     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00264-007-0360-7     Document Type: Article

References (17)

1. Bauer KA, Eriksson BI, Lassen MR, Turpie AG (2001) The steering committee of the pentasaccharide in major knee surgery study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 345(18):1305-1310
2. Boneu B, Necciari J, Cariou R et al (1995) Pharmacokinetics and tolerance of the natural pentasaccharide (SR90107/ORG31540) with high affinity to antithrombin III in man. Thromb Haemost 74(6):1468-1473
3. Eriksson BI, Bauer KA, Lassen MR, Turpie AG (2001) The Steering committee of the Pentasaccharide in Hip-fracture surgery study. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective hip-fracture surgery. N Engl J Med 345(18):1298-1304
4. Eriksson BI, Lassen MR, PENTasaccharide in HIp-FRActure Surgery Plus Investigators (2003) Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 163(11):1337-1342
5. Fujita S, Hirota S, Oda T, Kato Y, Tsukamoto Y, Fuji T (2000) Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop 375:168-174
6. Geerts WH, Heit JA, Clagett GP, Pineo GF, Colwell CW, Anderson FA Jr, Wheeler HB (2001) Prevention of venous thromboembolism. Chest 119(1 Suppl):132S-175S
7. Geerts WH, Pineo GF, Heit JA et al (2004) Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic therapy. Chest 126(3 Suppl.):S338-S400
8. Herbert JM, Petitou M, Lormeau JC, Cariou R, Necciari J, Magnani HN et al (1997) SR 90107A/Org 31540, a novel anti-factor Xa antithrombic agent. Cardiovasc Drug Rev 15(1):1-26
9. Hirsh J, Hoak J (1996) Management of deep vein thrombosis and pulmonary embolism: a statement for healthcare professionals. From the council on thrombosis (in consultation with the Council on Cardiovascular Radiology), American Heart Association. Circulation 93(12):2212-2245
10. Lassen MR, Bauer KA, Eriksson BI, Turpie AG (2002) The European Pentasaccharide Hip Elective Surgery Study (EPHESUS) Steering Committee. Postoperative fondaparinux versus preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 359(9319):1715-1720
11. Mann KG (1999) Biochemistry and physiology of blood coagulation. Thromb Haemost 82(2):165-74
12. Prescribing Information for Arixtra (fondaparinux). GlaxoSmithKline web site at http://us.gsk.com/products/assets/us_arixtra.pdf
13. Statistics and Information Department, Ministry of Health and Welfare: Patient Survey (1993) Tokyo, Japan (Japanese)
14. Statistics and Information Department, Ministry of Health and Welfare: Vital Statistics of Japan [Data compiled from 1964 to 1994] Tokyo, Japan. (Japanese)
15. Summary of Product Characteristics of fondaparinux. European Medicines Agency web site at http://www.emea.eu.int/humandocs/PDFs/EPAR/arixtra/H-403-PI- en.pdf#search='arixtra'
16. Turpie AG, Gallus AS, Hoek JA (2001) Pentasaccharide Investigators. A synthetic pentasaccharide for the prevention of deep-vein thrombosis after total hip replacement. N Engl J Med 344(9):619-625
17. Turpie AG, Bauer KA, Eriksson BI, Lassen MR (2002) The PENTATHLON 2000 Study Steering Committee. Postoperative fondaparinux versus postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 359(9319):1721-1726